Dongjian Li

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The molecular that used as prognosis and potential therapy target is urgently needed in hepatocellular carcinoma (HCC). In current work, we found the expression of CHAD (chondroadherin) was significantly reduced in hepatocellular carcinoma compared to the normal tissue, on both mRNA and protein levels, in three independent datasets. Survival analysis was(More)
  • 1